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MDA5 is an essential intracellular sensor for several
viruses, including picornaviruses, and elicits antiviral
interferon (IFN) responses by recognizing viral
dsRNAs.MDA5hasbeen implicated in autoimmunity.
However, the mechanisms of how MDA5 contributes
to autoimmunity remain unclear. Here we provide
direct evidence that dysregulation of MDA5 caused
autoimmune disorders. We established a mutant
mouse line bearingMDA5mutation by ENUmutagen-
esis, which spontaneously developed lupus-like
autoimmune symptoms without viral infection.
Inflammation was dependent on an adaptor mole-
cule, MAVS indicating the importance of MDA5-
signaling. In addition, intercrossing the mutant mice
with type I IFN receptor-deficient mice ameliorated
clinical manifestations. ThisMDA5mutant could acti-
vate signaling in the absence of its ligand but was
paradoxically defective for ligand- and virus-induced
signaling, suggesting that the mutation induces a
conformational change in MDA5. These findings pro-
vide insight into the association between disorders of
the innate immune system and autoimmunity.
INTRODUCTION
Innate immune responses including induction of type I inter-
ferons (IFNs) are initiated by receptors, which sense the invasionof microorganisms such as viruses and facilitate eradication of
pathogens. Several transmembrane protein members, Toll-like
receptors (TLRs), have been demonstrated to play an important
role in antiviral responses by recognizing pathogen-specific
molecular patterns (PAMPs) derived from viral species (Beutler,
2009; Imler and Hoffmann, 2001; Kawai and Akira, 2011) at the
cell surface or in endosomes. In the cytoplasm, it has been
shown that viral RNAs are sensed by RIG-I-like receptors
(RLRs), which consist of three family member molecules,
RIG-I, MDA5, and LGP2 (Yoneyama and Fujita, 2009). Cytosolic
DNA also activates DNA sensors such as DDX41, IFI16, and
cGAS to produce type I IFN (Sun et al., 2013; Unterholzner
et al., 2010; Zhang et al., 2011).
RLRs are encoded by IFN-inducible genes and are expressed
in various types of cells, including mouse embryonic fibroblasts
(MEFs), dendritic cells (DCs), and macrophages. In conventional
DCs (cDCs), RLRs play an essential role in antiviral defense,
whereas TLRs play an essential role in plasmacytoid DCs
(pDCs) for antiviral responses (Kato et al., 2005). These sensors
discriminate non-self and self-nucleic acids by their molecular
structure in a sequence-independent manner. For instance,
RIG-I is activated by double-stranded RNA (dsRNA) and is also
known to recognize RNAs with a triphosphate moiety at 50 end
and/or polypyrimidine (Hornung et al., 2006; Pichlmair et al.,
2006; Schlee et al., 2009; Takahasi et al., 2008). MDA5 also de-
tects dsRNA, such as poly(I:C), especially longer than 2 kbp in
length (Kato et al., 2008).
Type I IFNs produced by the innate immune response, so
called IFN responses, are the first line and major source of
host antiviral defense. However, there is also an implication
that excessive production of type I IFNs could rather cause aImmunity 40, 199–212, February 20, 2014 ª2014 Elsevier Inc. 199
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MDA5 Mutant Mice Cause Spontaneous Nephritispredisposition to autoimmunity (Trinchieri, 2010). There is also a
murine model in which nucleic acid accumulates within cells,
leading to excessive production of type I IFNs to cause autoim-
munity (Yoshida et al., 2005). Some studies revealed the involve-
ment of TLRs in autoimmunity. For example, TLR7 and TLR9 are
important for autoantibody production in a murine model of
lupus (Christensen et al., 2006), and spontaneous gene duplica-
tion of murine TLR7 causes a predisposition to autoimmunity
(Pisitkun et al., 2006).
MDA5 (encoded by IFIH1 in human) is associated with spe-
cific autoimmune diseases. A genome-wide association study
(GWAS) revealed that SNPs of IFIH1 (E627* and I923V), which
are supposed to be loss-of-function mutations (Shigemoto
et al., 2009), are significantly associated with resistance to
type 1 diabetes (Nejentsev et al., 2009). In amyopathic dermato-
myositis patients, anti-CADM140 antibodies, which could poten-
tially target MDA5, were detected in patients’ sera (Nakashima
et al., 2010). These findings imply a link between MDA5 and
autoimmune diseases; however, the link remains to be deter-
mined and little is known about the specific mechanisms that
lead to disease.
Here, we investigated the association of MDA5 with autoim-
munity in a mouse model. We found that mutant mice,
harboring a single missensemutation G821S inMDA5 generated
by N-ethyl-N-nitrosourea (ENU) mutagenesis, spontaneously
developed lupus-like nephritis and systemic autoimmune symp-
tomswithout viral infection. Here we provide direct evidence that
dysregulation of an innate immune sensor, MDA5, causes auto-
immune disorders.
RESULTS
ENU Mutagenesis and Identification of Responsible
Gene
ENU mutagenesis and phenotype screenings were carried out
as previously reported (Toki et al., 2013). Briefly, male C57BL/
6JJcl (B6) mice were treated with ENU and then mated with
DBA/2JJcl (D2) females. In the process of the dominant pheno-
type screenings in the F1 progeny, we detected phenodeviants
showing lupus-like nephritis. The inheritance of this phenotype
was confirmed in N2 progeny backcrossed to D2, and the
phenotype was mapped to 1.04 megabase (Mb) region in chro-
mosome 5 (see Figure S1A available online). We conducted
genomic DNA sequencing of all exons and splice sites of all
genes in this region. In consequence, one single-base substitu-
tion in exon 13 of Ifih1, resulting in amino acid exchange G821S
(gs), was identified (Figure S1B). Thus, we concluded that thisFigure 1. MDA5 G821S Mutant Mice Spontaneously Develop Lupus-lik
(A) Histology of kidney from Ifih1+/+ and Ifih1gs/+ mice (left panels, Haematoxylin-
(B) Body weight change of Ifih1+/+ and Ifih1gs/+ male and female mice following t
Ifih1gs/+ female, n = 13.
(C) Survival curve of Ifih1+/+ (n = 30) and Ifih1gs/+ (n = 28) mice in DBA/2JJcl back
Statistical significance was determined by Log rank test. *p < 0.03, NS; not sign
(D) Immunoglobulin and complement 3(C3) depositions on Ifih1gs/+ kidney.
(E) Production of anti-nuclear antibodies (ANA) and anti-double-stranded DNA (a
(F) Hypergammaglobulinemia in Ifih1gs/+ mice. Serum immunogloblin levels are s
*p < 0.03.
(G) Amounts ofmRNA in kidney for indicated geneswere quantified by quantitative
with standard as mean ± SD of duplicate samples of a representative from threemutation was responsible for the phenotype. The F1 founder
was backcrossed five generations to D2, and N6 progeny were
subjected to a series of analyses.
Ifih1 gsMutant Mice Develop Spontaneous
Inflammation in Multiorgans
Major organs in mutant mice were analyzed histologically.
Among several clinical manifestations, we found that nephritis
was significant and reproducible in all heterozygous (Ifih1gs/+)
descendants, developing from 6 to 8 weeks after birth (Figures
1A and S1C). In addition to nephritis, most Ifih1 gs/+ mice with
a DBA/2 background developed severe multiorgan autoimmune
disease. They showed growth retardation (Figure 1B), and 60%
of the mutant died within 24 weeks after birth (Figure 1C).
There was mild infiltration of polymorphonuclear leukocytes in
the haired skin of the forehead (Figure S1D). We also found
calcification in the liver, which indicates chronic inflammation
(Figure S1D). Of note, homozygotes developed more severe
inflammation and rarely survived for 4 weeks after birth (data
not shown). In the affected kidney, deposition of immunoglobulin
and complement was observed (Figure 1D). Anti-nuclear anti-
bodies (ANA) and anti-dsDNA antibodies were detected in the
sera of Ifih1gs/+ mice (Figure 1E). Ifih1gs/+ mice developed hyper-
immunoglobulinemia of all tested immunoglobulin classes (Fig-
ure 1F). These pathological and serological features were
consistent with lupus-like nephritis. In the kidney, production of
inflammatory cytokines and chemokines including IFN-b, inter-
leukin-6 (IL-6), CXCL10, Isg56, and tumor necrosis factor-a
(TNF-a) was significantly upregulated (Figure 1G). Upregulation
of IFN-b and IL-6 in systemic organs was observed (Figure S1E),
suggesting that chronic inflammation occurred in multiple
organs, including the kidney of Ifih1gs/+, although nephritis was
especially evident. Consistent with the upregulation of IFN in
multiorgans, increased mRNA of RLRs, as well as protein was
detected (Figures S1F and S1G). In summary, the mice exhibit
continued upregulation of IFN and IFN-stimulated genes in mul-
tiple organs.
Intrinsically Activated DCs and Macrophages Are
Possible Sources of Chronic Inflammation
MDA5 protein is ubiquitously expressed in multiorgans and
various types of cells, including nonimmune cells such as fibro-
blasts and immune cells including DCs and macrophages.
Abnormal function of innate immune cells is considered a predis-
posing factor for systemic lupus erythematosus (SLE) because
they produce robust type I IFNs and activate adaptive immune
system to trigger autoimmunity (Liu and Davidson, 2012). Toe Autoimmune Disorder
eosin staining; right panels, PAS).
ime course. Ifih1+/+ male, n = 14; Ifih1+/+ female, n = 15; Ifih1gs/+ male, n = 12;
ground (upper) and of male (n = 12) and female (n = 16) Ifih1gs/+ mice (lower).
ificant.
nti-dsDNA) antibodies in Ifih1gs/+ sera.
hown. Statistical significance in (E) and (F) was determined by Student’s t test.
real-time PCR.Mean relative expression against littermateWT kidney is shown
independent experiments. Open histogram, Ifih1+/+; closed, Ifih1gs/+ kidney.
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mation, we analyzed spleen cells by flow cytometry. Ifih1gs/+
mice, both cDCs (CD11chiB220lo) and pDCs (CD11cintB220hi),
and macrophages (CD11bhiF4/80int) were increased in numbers
and their cell surface marker, CD86, was upregulated (Figures
2A and 2B), suggesting that these DCs and macrophages are
activated. Next, we sorted these cells and examined the induced
amount of type I IFN and Cxcl10 (Figure 2C), as well as IL-6 (Fig-
ure S2A). As we expected, marked upregulation of these genes
was detected in DCs and macrophages, whereas no upregula-
tion was observed in T and B cells. Of note, when cDCs and
macrophages were differentiated from bone marrow cells in
the presence of GM-CSF, IFN induction and slight upregulation
of CD86 were clearly observed (Figure 2D; data not shown),
suggesting that DCs and macrophages in Ifih1gs/+ mice are
activated intrinsically, as well as through a bystander activa-
tion. Next we examined other cell types, including T cells and
B cells. The ratio of T cells and B cells was normal in Ifih1gs/+
splenocytes (Figure S2B). Effector (CD44hiCD62Llo) andmemory
(CD44hiCD62Lhi) T cells were increased, whereas naive T
(CD44loCD62Lhi) cells were decreased in Ifih1gs/+ mice (Fig-
ure S2C). We detected upregulation of an activation marker
CD69 in CD4+ and CD8+ T cells. Although no significant activa-
tion was observed in the B cell population with the cell surface
markers, GL7 and CD69 (Figure S2D), plasma cell population
was slightly increased and absolute cell number was higher in
Ifih1gs/+ mice (Figure 2E), which could lead to augmentation of
antibody production (Figures 1E and 1F). Consistent with sys-
temic inflammation, granulocytes were significantly increased
in Ifih1gs/+ mice (Figures S2E and S2F). Thus, we identified that
DCs and macrophages were primary source of type I IFN and in-
flammatory cytokines, which could induce effector T cells and
plasma cells, consequently leading to antibody production.
Hematopoietic Cells Are Involved in Nephritis
To access the contribution of hematopoietic cells to the chronic
inflammation, we transferred bone marrow cells by reconstitut-
ing irradiated DBA/2 wild-type (WT) mice with Ifih1+/+ or Ifih1gs/+
bone marrow cells (Figure 3A). The mice with transferred bone
marrow cells from Ifih1gs/+ displayed nephritis (Figure 3B) and
immunoglobulin deposition in the kidney (Figure 3C) beginning
6 weeks after reconstitution. In the kidney, significant induction
of inflammatory cytokines was detected (Figure 3D). In the
spleen, upregulation of CD86 in both cDCs and pDCs was
observed (Figure 3E). These results indicate that hematopoietic
cells are sufficient for MDA5 mutation-dependent nephritis. Of
note, those recipient mice exhibited a relatively milder pheno-
type than Ifih1gs/+ mice, implicating that not only hematopoieticFigure 2. Intrinsically Activated DCs and Macrophages Are Possible S
(A and B) Splenocytes were stained with CD11c and B220 (A) or CD11b and F4
cytometry. pDCs and cDCs (A) and macrophages (B) were additionally gated and
fluorescent intensity (MFI) was quantified in bar graphs. Closed histogram, Ifih1+/+
*p < 0.03.
(C) Indicated immune cells were sorted from spleen and indicated mRNA expres
mean ± SD of duplicate samples of a representative from two independent expe
(D) Bone-marrow-derived dendritic cells were sorted by MACS on day 6 and thei
(E) Left shows splenocytes were stained with CD19 /CD138 and analyzed by FAC
Statistical significance was determined by Student’s t test. **p < 0.05.cells but also nonhematopoietic cells could possibly be involved
in MDA5 mutation-dependent nephritis.
Critical Role of MAVS in the Development of Nephritis in
Ifih1gs/+ Mice
MAVS is the key adaptor molecule for the RLR pathway to trans-
duce signaling downstream (Kawai et al., 2005; Meylan et al.,
2005; Seth et al., 2005; Xu et al., 2005). To clarify the involvement
of G821S MDA5 mutation in chronic inflammation, we inter-
crossed Ifih1gs/+ mice with Mavs/ mice with a C57BL/6 back-
ground. Ifih1gs/+Mavs+/ mice developed nephritis with a less
severe clinical score than Ifih1gs/+,Mavs+/+ mice (Figures 4A
and 4B). In contrast, Ifih1gs/+,Mavs/ mice were devoid of
nephritis and remained healthy. Moreover, production of type I
IFNs and inflammatory cytokines in the kidney was revealed to
be dependent on the gene dosage of Mavs; notably, virtually
no production of these cytokines was detected in the absence
of MAVS (Figure 4C). Consistent with our observation, virus-
induced type I IFN production is reported to be dependent on
Mavs gene dosage (Seth et al., 2005). Further, when CD11c+
cells in the spleen were examined, type I IFN gene expres-
sion observed in Ifih1gs/+,Mavs+/ cells was abolished in
Ifih1gs/+,Mavs/ cells (Figure 4D). Although the number of
effector CD4+ T and effector CD8+ T cells was increased in the
Ifih1gs/+,Mavs+/ spleen compared with the Ifih1+/+,Mavs+/
spleen, additional deletion of the Mavs gene (Ifih1gs/+,Mavs/)
abolished the increase of these effector cells (Figure S3A). In
addition, activation of cDC and pDC as judged by the increase
of CD86 expression, was similarly corrected by deletion of the
Mavs gene (Figure S3B). These results strongly suggest that
the observed kidney pathology, constitutive production of type
I IFN and cytokines, and increase and activation of effector
T cells and DCs are caused by a mutated Ifih1 allele. Further-
more, the MDA5-MAVS axis is the key molecular basis for the
pathogenesis in MDA5 gs mutant mice.
Type I IFN Signaling Contributes to But Is Not Essential
for MDA5-Dependent Nephritis
Emerging evidence has implicated dysregulated type I IFN pro-
duction as a key predisposing factor for autoimmune diseases
including SLE (Banchereau and Pascual, 2006). MDA5 signaling
causes type I IFN induction as well as other cytokines. To further
investigate the contribution of type I IFNs in the current autoim-
mune model, we intercrossed Ifih1gs/+ mice with Ifnar1/ mice
on a C57BL/6 background. Ifih1gs/+Ifnar1/ mice had partially
ameliorated nephritis; however, they still developed substantial
pathology in the kidney (Figures 5A and 5B). In the affected kid-
ney, slight induction of type I IFNs and inflammatory cytokinesources of Chronic Inflammation
/80 (B) after MACS depletion of CD3+ and CD19+ cells and analyzed by flow
their CD86 expression was accessed in histogram and quantification of mean
; red open, Ifih1gs/+. Statistical significance was determined by Student’s t test.
sion levels were determined by quantitative real-time PCR. Data are shown as
riments.
r IfnbmRNA expression levels were determined by quantitative real-time PCR.
S. Right shows absolute cell counts of plasma cells were shown in bar graphs.
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partially responsible for the pathogenesis, whereas the other
inflammatory cytokines are potentially responsible for the
pathology of MDA5 gs mutant mice.
G821S Mutation of MDA5 Is Unresponsive to RNA
Ligands but Constitutively Active
We examined Ifnb expression in MEFs expressing the G821S
MDA5 mutation. Ifih1gs/gs MEFs clearly expressed Ifnb gene in
the absence of cellular stimuli and Ifih1gs/+ MEFs exhibited lower
but significant upregulation compared to Ifih1+/+ MEFs (Fig-
ure 6A), suggesting that theG821Smutation confers gain of func-
tion. To further confirm this notion, expression vectors for human
MDA5 and its mutants were transiently expressed in cultured
cells. In addition to G821S, which was conserved at the same
amino acid position in human IFIH1, another mutation, A946T,
which has been implicated in the relation with SLE, was tested
(Gateva et al., 2009). Expression of human G821S and human
A946T mutants strongly activated IFN-b promoter in Huh-7 cells
(Figure 6B), suggesting that these mutations conferred intrinsic
activation function on MDA5. Next, to examine cell-type speci-
ficity in the mouse system, we introduced mutant MDA5 to
Ifih1/DCswith retroviral vectors (Figure 6C).WTMDA5expres-
sion resulted inconstitutiveexpressionof Ifnb,which isconsistent
with a previous notion that MDA5 exhibits constitutive activity
when overexpressed. However, MDA5 gs exhibited significantly
higher activity than the WT. These data indicate the importance
of a conserved G821 region in mouse and human MDA5 to sup-
press autoactivation in both hematopoietic and nonhemato-
poietic cells. We next investigated IFN-b production in WT and
mutant MEFs upon viral infection (Figures 6D and 6E). EMCV
infection is exclusively detected by MDA5, whereas infection by
Newcastle disease virus (NDV) infection is exclusively detected
by RIG-I (Kato et al., 2006). Upon EMCV infection, Ifih1+/+ and
Ifih1gs/+ MEFs produced high levels of IFN-b; however, Ifih1gs/gs
MEFs did not (Figure 6D). When these MEFs were infected with
NDV, efficient production of IFN-bwas observed due to the func-
tion of RIG-I in these cells (Figure 6E). Further, to clarify the
response of A946T mutant, we introduced the mutant MDA5 to
Ifih1/ MEFs with expression vector and concluded that
A946T could not respond to EMCV (Figure 6F). These results
demonstrate that although G821S and A946T mutations confer
constitutiveactivity, theydisrupt responsiveness toviral infection.
G821S and A946T Mutations Lead to Conformational
Change and Abrogate ATPase Activity of MDA5
To characterize the physicochemical properties of MDA5 gs and
A946T, we produced recombinant MDA5 proteins. The purity ofFigure 3. Hematopoietic Cells Are Involved in Renal Pathogenesis
(A) Schematic diagram of bone-marrow-transfer experiments.
(B) Histology of kidney from Ifih1+/+ and Ifih1gs/+ bone-marrow-transferred mice
(C) Immunoglobulin and C3 depositions on kidney from Ifih1+/+ and Ifih1gs/+ bon
(D) mRNA expression of kidney from Ifih1+/+ and Ifih1gs/+ bone-marrow transferre
SD of duplicate samples of a representative from three independent experiments
Ifih1gs/+ bone-marrow transferred mice.
(E) Whole splenocytes were prepared and stained with CD11c and B220. pDCs an
(middle) and quantification of mean fluorescent intensity (MFI) was quantified in
splenocytes. Statistical significance was determined by Student’s t test. *p < 0.0the recombinant MDA5 proteins were confirmed by SDS-PAGE
(Figure 7A). First, the recombinant proteins were examined by
an atomic force microscope (AFM) (Figure 7B). WT MDA5
appeared as three closely associated lumps, whereas MDA5
gs and A946T were observed as a single blunt lump. Quantifica-
tion confirmed that MDA5 gs, A946T, and WT have distinct
molecular shapes, suggesting open and closed conformations,
respectively. We next examined ATPase activity because
MDA5 is a dsRNA-dependent ATPase (Sumpter et al., 2005). In
the absence of dsRNA, WT MDA5 exhibited very low ATPase
activity, which was markedly enhanced in the presence of
polyI:C. In contrast, ATPase activity of neither MDA5 gs nor
A946T was augmented even in the presence of polyI:C (Fig-
ure 7C), consistent with the result that MDA5 gs and A946T failed
to respond to viral infection (Figures 6D and 6F). Thus, the
constitutive activity of MDA5 gs and A946T is likely a result of
conformational alteration rather than hyperresponsiveness to
endogenous RNA ligand.
DISCUSSION
Type I IFNs are associated with a number of human autoimmune
diseases including SLE. Here we described themolecular mech-
anisms of a type I IFN-mediated autoimmune disorder in a
mouse model. We identified lupus-like features, as well as upre-
gulation of type I IFNs and cytokines, in multiorgans of MDA5
mutant mice. We showed that MAVS is essential for autoimmune
disorders in MDA5 gs mice; thus, MDA5-dependent signaling
throughMAVS is critical for the pathogenesis of autoimmune dis-
ease associated with MDA5mutation. Of note, MDA5 transgenic
mice have been reported to upregulate the production of anti-
nuclear antibodies in sera on an FcgR2b-deficient background,
leading to glomerulonephritis (Crampton et al., 2012); however,
MDA5 overexpression was not sufficient to develop autoimmune
symptoms, suggesting that the magnitude of constitutive sig-
naling by WT MDA5-overexpression is negligible compared to
that by single copy of MDA5 gs. In accordance with this, no
gene amplification but a point mutation of Ifih1gs has been impli-
cated in human autoimmune diseases (Gateva et al., 2009).
It was surprising that the amount of IFN-bproduced by Ifih1gs/+
and Ifih1gs/gs cells was far lower than that produced upon viral
infection. However, it was sufficient to cause severe symptoms
in mice. We can explain this by hypothesizing a cell-intrinsic
mechanism: MDA5 gs possibly takes an autoactivated form
even in the absence of RNA ligands, subsequently leading to
constitutive signal transduction via MAVS. Consequently, it re-
sults in chronic activation of the type I IFN pathway through
IRF3, IRF7, NF-kB, and MAP kinases, resulting in upregulation(left panels, Haematoxylin-eosin staining; right panels, PAS).
e-marrow-transferred mice.
d mice was determined quantitative real-time PCR. Data are shown as mean ±
. Open histogram shows Ifih1+/+ bone-marrow transferred mice; closed shows
d cDCswere gated (left) and their CD86 expression was accessed in histogram
bar graphs (right). Closed histogram shows Ifih1+/+; red open shows Ifih1gs/+
3.
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IFN-inducible genes.
Such chronic activation should take place in all cell types and
is therefore sufficient to trigger biological consequences. This
hypothesis is consistent with the result that deletion of MAVS
but not IFNAR1 completely abrogated the pathology. Because
hematopoietic Ifih1gs/+ cell transfer is sufficient to reproduce
the disorder and DCs andmacrophages upregulate a cell activa-
tion marker, CD86, we propose DCs and macrophages as the
primary cell types for initiating autoimmunity in Ifih1gs/+ mice.
The partial effect of type I IFN receptor deletion on rescue from
the symptoms suggests the potential involvement of other in-
flammatory cytokines, including IL-6 and TNF-a, for amplifying
the activation cascade, leading to the effector T cells and anti-
body production.
These observations suggest possible therapies targeting the
pathway to arrest disease progression. For example, reagents
that modify the molecular structure of MDA5 or direct blocking
of the interaction between MDA5 and MAVS or inhibition of
downstream kinases will provide fundamental therapy. Tempo-
ral depletion of DCs and macrophages would potentially amelio-
rate inflammation and tissue damage. Conversely, blocking
ATPase activity of MDA5 gs and A946T would not provide ther-
apeutic effect because gs and A946T are negative for ATPase
activity.
Crystal structures of RIG-I suggest that free RIG-I has an open
structure in which CARD is masked by interactions with helicase
domain 2, thus being inactive for signaling (Kowalinski et al.,
2011). Upon binding with dsRNA, it markedly changes the
conformation into a more packed structure, thereby releasing
CARD. We propose a similar scenario for WT MDA5, which
has an open structure with CARD masked; however, G821S
mutation results in conformational change as revealed by AFM
analysis.
Paradoxically, in the response to viral infection, gs is unable to
further upregulate IFN. We propose that the gs mutation resulted
in constitutive activity rather than being hypersensitive to
endogenous RNA ligands. This hypothesis is supported by the
observations; gs does not exhibit ATPase activity, even in the
presence of dsRNA; AFM analysis revealed that purified gs pro-
tein takes distinct conformation from WT protein. It appears that
gene induction by virus infection in WT cells is far more efficient
than constitutive gene expression resulting from Ifih1gs/+ muta-
tion. This is possibly because WT MDA5 is efficiently activated
by binding with viral dsRNA to form a fiber-like polymer to facil-
itate a signaling relay (Wu et al., 2013); however, MDA5 gs is acti-
vated without such polymerization.
Within human IFIH1 SNPs, A946T has been reported to be a
risk variant for SLE (Gateva et al., 2009). This missense mutation
is implied to be a gain-of-function mutation in SLE (RobinsonFigure 4. MAVS Is Critical for the Development of Nephritis in Ifih1gs/+
(A) Histology of kidney from WT, Ifih1gs/+・Mavs+/, or Mavs/ mice (left panels
(B) Histological scores and percentage of sclerosis in kidney fromWT, Ifih1gs/+・M
determined by Student’s t test. *p < 0.03.
(C) Indicated mRNA gene expression levels in kidney from WT, Ifih1gs/+・Mavs+
Littermate mice were subjected and data are shown as mean ± SD of duplicate
(D) CD11c+ cells were sorted from splenocytes of indicated mice and their mRNA
mean ± SD of duplicate samples of a representative from three independent expet al., 2011). We found that A946T, like G821S, constitutively
activated IFN signaling. In addition, MDA5 A946T takes packed
structure as observed by AFM and does not exhibit ATPase
activity even in the presence of dsRNA. These features resemble
those of G821S. Consistent with our observation, it was reported
that mutations in MDA5 helicase motif I, III, and VI lead to
constitutive IFN signaling with inactivation of ATPase activity
(Bamming and Horvath, 2009). Furthermore, constitutive active
mutants of RIG-I (mut1 and 2) exhibit no ATPase activity (Ka-
geyama et al., 2011).
Increasing number of reports revealed that the molecules
involved in innate immune signal pathways are associated
with the development of inflammatory diseases. For example,
NOD1 and NOD2 sense cytosolic peptidoglycan and muramyl
dipeptide (MDP), respectively, and activate MAPK and NF-kB-
dependent pathway (Elinav et al., 2011). Variants of NOD2 are re-
ported to increase the susceptibility to Crohn’s disease (CD)
(Hugot et al., 2001; Ogura et al., 2001). These mutations abolish
the ability to sense MDP and fail to activate NF-kB in peripheral
blood mononuclear cells (van Heel et al., 2005), whereas over-
production of NF-kB-regulated genes including TNF-a, IL-1b,
and IL-6 in epithelial cells and lamina propria macrophages are
detected in CD patients. These paradoxical immune responses
might resemble those mediated by MDA5 gs. In a basal state,
MDA5 gs weakly but constitutively activates IFN signaling in
the absence of ligand leading to persistent chronic inflammation.
Conversely, in viral infection, MDA5 gs is defective in antiviral
immune response for limiting inflammation, which could poten-
tially underlie susceptibility to viral infection. For another inflam-
matory disease-associated molecule in NOD family, NALP-3
mutations are associated with three different autosomal dis-
eases, Muckle-Wells syndrome (MWS), chronic infantile neuro-
logical cutaneous and articular (CINCA) syndrome, and familial
cold autoinflammatory syndrome (FACS) (Bihl et al., 2005; Hoff-
man et al., 2001). These NALP-3 mutations result in an increased
processing of pro-IL-1b and subsequent release of the active
cytokine (Dinarello, 2004). These observations support gain-of-
functional model for triggering chronic inflammation and provide
a clue for understanding the mechanism of autoinflammatory
disorders.
Some intracellular molecules that regulate degradation of
nucleic acid have been linked to autoimmune disorders. For
example, TREX1 is a major exonuclease that degradates endog-
enous DNA. In Trex1/ mice, cell-intrinsic ligands activate IFN
signaling, consequently leading to autoimmunity (Gall et al.,
2012; Stetson et al., 2008), linking the association that human
genetic mutations in Trex1 cause Aicardi-Goutieres syndrome
(AGS) and chilblain lupus. In comparison, we defined MDA5 gs
mutation as gain of function in basal state, but not hypersensitive
to endogenous RNA ligands (above).Mice
, Haematoxylin-eosin staining; right panels, PAS).
avs+/+,Mavs+/, orMavs/mice were evaluated. Statistical significance was
/+, Mavs+/, or Mavs/ mice were determined by quantitative real-time PCR.
samples of a representative from three independent experiments.
expression was determined by quantitative real-time PCR. Data are shown as
eriments.
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D E F
Figure 6. G821S Mutation of MDA5 Is Unre-
sponsive to RNA Ligands but Constitutively
Active
(A) Basal IfnbmRNA level in MEFs are shown. Data
are shown as mean ± SD of duplicate samples.
Statistical significance was determined by Stu-
dent’s t test. *p < 0.03, **p < 0.05.
(B) Huh7 cells were transfected with a reporter
gene (p-55C1B Luc) and empty vector (BOS) or
expression vectors for FLAG-tagged human
MDA5 and MDA5 mutants. Forty-eight hr after the
transfection, luciferase activity was determined
and indicated protein expression was accessed in
SDS-PAGE. Statistical significance was deter-
mined by Student’s t test. *p < 0.03.
(C) Ifnb mRNA levels in GM-CSF induced DCs
expressing WT MDA5 and MDA5 gs. The DCs
were infected with retroviruses, which introduce
indicated genes and GFP independently. Forty-
eight hr after infection, they were sorted
according to GFP expression by FACS and sub-
jected to quantitative real-time PCR. Data are
shown as mean ± SD of duplicate samples of a
representative from two independent experi-
ments. Indicated gene expression in GFP (+) cells
was shown by RT-PCR in the right panel. Statisti-
cal significance was determined by Student’s
t test. *p < 0.03.
(D and E) IFN-b concentration in culture superna-
tant fromMEFs infected with various titer of EMCV
(D) or NDV (E) for 24 hr were measured by ELISA.
Data are shown as mean ± SD of duplicate sam-
ples of a representative from three independent
experiments.
(F) Ifih1/ MEFs were transfected with empty
vector or expression vector for human WT MDA5
or MDA5 A946T and a reporter, p-55C1B Luc.
Forty-eight hr after the transfection, the cells were
infected with EMCV for 6 hr and IFN-b promoter
activity was determined. Statistical significance
was determined by Student’s t test. *p < 0.05.
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MDA5 Mutant Mice Cause Spontaneous NephritisIn summary, we describe the mechanisms of how MDA5
G821S mutation contributes to autoimmunity in a mouse model
and how human SNP of MDA5 A946T potentially associates to
autoimmune disorder. These findings provide insights into how
dysregulation of cell-intrinsic antiviral sensors leads to autoim-
munity and suggest approaches for therapeutic opportunities.
EXPERIMENTAL PROCEDURES
Mice
Ifih1gs/+ mice with a DBA/2 background were proliferated by in vitro fertilization
of Ifih1gs/+ sperm 3 DBA/2JJcl female ovum. Heterozygotes of G821S
MDA5 mutant with a DBA/2 background were analyzed as stated. Neither
sex nor litter effects were detected by ANOVA in the survival rate and histolog-
ical analysis and so data from different sexes and litters were analyzedFigure 5. Type I IFNs Are Partially Responsible but not Essential for M
(A) Histology of kidney from WT, Ifih1gs/+・Ifnar1+/, or Ifnar1/ mice (left panel
(B) Histological scores and percentage of sclerosis in kidney fromWT, Ifih1gs/+・If
determined by Student’s t test. *p < 0.03.
(C) Indicated mRNA gene-expression levels in kidney from Ifih1gs/+・Ifnar1+/+,
Littermate mice were subjected and data are shown as mean ± SD of duplicatetogether. Mavs/ mice were kindly provided from S. Akira (Osaka University)
and Ifnar1/ mice were purchased from B&K Universal. All animal experi-
ments were conducted in compliance with regulations approved by the
Committee for Animal Experiments of the Institute for Virus Research, Kyoto
University.
Cells, Virus, and Reagents
MEFs were prepared from 12.5–13.5 embryos generated by in vitro fertilization
of Ifih1gs/+3 Ifih1gs/+ with a DBA/2JJcl background and cultured in Dulbecco’s
modified Eagle’s medium (DMEM) with fetal bovine serum (FBS) and penicillin-
streptomycin (100 U/ml and 100 mg/ml, respectively). To prepare GM-CSF-
induced BMDCs, we prepared bone marrow cells from femora and tibia of
3- to 10-week-old mice. Cells were cultured in RPMI 1640 medium supple-
mented with 10% FBS, 100 mM 2-ME, and 10 ng/ml murine GM-CSF (Pepro-
tech). Mediumwas changed every 2 days. Encephalomyocarditis virus (EMCV)
was purchased from ATCC.DA-5 Dependent Nephritis
s, Haematoxylin-eosin staining; right panels, PAS).
nar1+/+, Ifnar1+/, or Ifnar1/mice were evaluated. Statistical significance was
Ifnar1+/, or Ifnar1/ mice were determined by quantitative real-time PCR.
samples of a representative from three independent experiments.
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Figure 7. G821S and A946T Mutations Lead
to Conformational Change and Abrogate
ATPase Activity of MDA5
(A) Purity of MDA5 recombinant protein by SDS
PAGE.
(B) Single-molecule analyses of theWT andmutant
MDA5 molecules by AFM. Top images were ob-
tained from 500 nm scans. Middle shows four in-
dividual molecules each in the WT and mutant
images are marked by arrow heads and depicted
in 100 nm zoomed-in scales. Bottom shows sec-
tion analyses where four individual height features
from the middle panels were superimposed, illus-
trating the height differences between the WT and
mutant molecules.
(C) ATPase activity of WT and mutant MDA5.
ATPase activity of the recombinant WT andmutant
MDA5 proteins were determined in the absence or
presence of polyI:C. Data are the mean ± SD of
duplicate samples of a representative of three
independent experiments.
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Tissues were fixed in 10% formalin, paraffin embedded, cut into sections
(5 mm), and stained with hematoxylin-eosin or Periodic acid-Schiff.
Quantitative Real-Time PCR
Total RNA was prepared with TRIzol reagent (Invitrogen), treated with DNase I
(Roche Diagnostics), and reverse-transcribed with a High-Capacity cDNA
Reverse Transcription Kit (Applied Biosystems) according to the manufac-
turer’s instructions. Reverse transcription-PCR was performed with the ABI210 Immunity 40, 199–212, February 20, 2014 ª2014 Elsevier Inc.PRISM 7700 sequence detection system (Applied
Biosystems) or the STEP One plus Real Time PCR
system (Applied Biosystems) and TaqMan Fast
Universal PCR Master Mix (Applied Biosystems).
TaqMan primers for mouse Ifnb1, IL-6, Cxcl10,
Isg56, Tnfa, and 18 s rRNA were purchased from
Applied Biosystems. The RNA copy numbers
were normalized to that of internal 18 s rRNA.
Flow Cytometry
Cell suspensions of the spleen were prepared by
sieving and gentle pipetting, and were treated
with red cell lysis. For surface staining, cells were
maintained in the dark at 4C throughout. Cells
were washed in ice-cold PBS, then incubated
with each antibody for 15 min and washed twice
with PBS. Antibodies for flow cytometry were pur-
chased from BioLegend, eBioscience, and BD
Biosciences. Data were acquired on the FACS
Canto II flow cytometer (BD Biosciences) and
analyzed with FlowJo.
Bone Marrow Chimeras
WTmicewith a DBA/2JJcl backgroundwere irradi-
ated with 8 Gy. Bone marrow cells from Ifih1+/+ or
Ifih1gs/+ mice were infused intravenously 6 hr after
irradiation. Mice were treated with antibiotics for
12 days after irradiation. To assess chimerism,
we determined the abundance of WT and MDA5
mutant alleles in genomic DNA obtained from the
spleen by PCR.
Plasmid Construct
The p-55 C1B Luc, pEF-BOS-FLAG MDA5 has
been described previously (Shigemoto et al.,2009). pEF-BOS-FLAG-MDA5G821S, A946Twere constructed by introducing
the mutations into pEF-BOS-FLAG MDA5 respectively with the KOD-Plus-
Mutagenesis Kit (TOYOBO).
Retroviral Expression
pLZR-IRES/GFP vector has been described previously (Satoh et al., 2010). A
murine WT MDA5 or MDA5 G821S cDNA was cloned into the pLZR-IRES/
GFP retroviral vector. The constructs were transfected into the packaging
cell line PlatE, and viral supernatants were collected 48 hr after transfection.
Immunity
MDA5 Mutant Mice Cause Spontaneous NephritisMeasurement of IFN-b Production
Cells were infected with EMCV, NDV for the indicated period. Culture superna-
tants were collected and analyzed for IFN-b with an enzyme-linked immuno-
sorbent assay (ELISA). ELISA kit for mouse IFN-b was purchased from PBL
Biochemical Laboratories.
Luciferase Reporter Assay
TheDual-Luciferase Reporter Assay System (Promega) was used according to
the manufacturer’s instructions for luciferase assays. As an internal control,
the Renilla Luciferase construct pRL-TK (Promega) was used.
Protein Purification
The cDNA encoding human WT MDA5, MDA5 G821S, or A946T was inserted
into pAcGHLT-B vector (BD Biosciences). To obtain recombinant baculovi-
ruses, Sf9 insect cells were cotransfected with the expression plasmid and
BD Baculo Gold Linearized Baculovirus DNA (BD Biosciences) according to
themanufacturer’s protocol. The recombinant MDA5 proteins were expressed
in Sf9 or High five insect cells (23 107 cells/150 mm dish) by infection with re-
combinant baculovirus for 4 days. The cells were lysed in lysis buffer (50 mM
Tris–HCl pH 8.0, 150 mM NaCl, 1.5 mM DTT, 1% Triton X-100) with protease
inhibitor cocktail (Nacalai Tesque). The lysates were purified with Ni-NTA
super-flow (QIAGEN) followed by glutathione Sepharose 4B (GE Healthcare)
according to the manufacturer’s instructions.
ATPase Assay
Reactionmixture (25 ml: 1 mg purified recombinant protein, 100 ng RNA, 20mM
Tris–HCl pH 8.0, 1.5 mMMgCl2, 1.5 mM DTT, 20 units Protector RNase Inhib-
itor (Roche), 1 mM ATP) was incubated at 37C for 30 min. The product, inor-
ganic phosphate, was quantified with BioMol Green (Enzo).
AFM Observation
AFM imaging of MDA5 was performed utilizing a Nanoscope IIIa/IV with a type
E or type J scanner (Digital Instruments) in air with the Tapping Mode at room
temperature. The probes usedweremade of silicon crystal, and the cantilevers
were 160 (±20) mm in length with a spring constant of 12–103 Nm1 (OMCL-
AC160TS; Olympus). Images were captured with the height mode in a 512 3
512 pixel format at a scanning frequency of 2 Hz. The images obtained were
plane-fitted and flattened with the computer program supplied in the imaging
module. The three-dimensional surface plots of the pictures were also pro-
duced with this program. For observation by AFM, purified WT/mutant
MDA5 was diluted in Tris buffer containing 20 mM Tris–Cl (pH 8.0), 1.5 mM
MgCl2, and 1.5mMDTT andwas applied to a freshly cleavedmica surface pre-
treated with 10 mM spermidine. After 10 min, the mica was washed with water
and dried with nitrogen gas.
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